Page last updated: 2024-08-17

levodopa and cy 208-243

levodopa has been researched along with cy 208-243 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agid, Y; Bonnet, AM; Jenner, PG; Lataste, X; Markstein, R; Marsden, CD; Pourcher, E; Quinn, NP; Temlett, JA	1

Other Studies

1 other study(ies) available for levodopa and cy 208-243

Article	Year
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1989, Volume: 4, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Analgesics; Animals; Callitrichinae; Dopamine Agents; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Phenanthridines; Pyridines	1989

Article

Year

Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 1989, Volume: 4, Issue:3

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Analgesics; Animals; Callitrichinae; Dopamine Agents; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Phenanthridines; Pyridines

1989